• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸外科医师协会先天性心脏病手术数据库公开报告倡议

The Society of Thoracic Surgeons Congenital Heart Surgery Database Public Reporting Initiative.

作者信息

Jacobs Jeffrey P

机构信息

Division of Cardiovascular Surgery, Department of Surgery, Johns Hopkins All Children's Heart Institute, Johns Hopkins All Children's Hospital and Florida Hospital for Children, Saint Petersburg, Tampa, and Orlando, FL; Division of Cardiac Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.

出版信息

Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2017 Jan;20:43-48. doi: 10.1053/j.pcsu.2016.09.008.

DOI:10.1053/j.pcsu.2016.09.008
PMID:28007064
Abstract

Three basic principles provide the rationale for the Society of Thoracic Surgeons (STS) Congenital Heart Surgery Database (CHSD) public reporting initiative: (1) Variation in congenital and pediatric cardiac surgical outcomes exist. (2) Patients and their families have the right to know the outcomes of the treatments that they will receive. (3). It is our professional responsibility to share this information with them in a format they can understand. The STS CHSD public reporting initiative facilitates the voluntary transparent public reporting of congenital and pediatric cardiac surgical outcomes using the STS CHSD Mortality Risk Model. The STS CHSD Mortality Risk Model is used to calculate risk-adjusted operative mortality and adjusts for the following variables: age, primary procedure, weight (neonates and infants), prior cardiothoracic operations, non-cardiac congenital anatomic abnormalities, chromosomal abnormalities or syndromes, prematurity (neonates and infants), and preoperative factors (including preoperative/preprocedural mechanical circulatory support [intraaortic balloon pump, ventricular assist device, extracorporeal membrane oxygenation, or cardiopulmonary support], shock [persistent at time of surgery], mechanical ventilation to treat cardiorespiratory failure, renal failure requiring dialysis and/or renal dysfunction, preoperative neurological deficit, and other preoperative factors). Operative mortality is defined in all STS databases as (1) all deaths, regardless of cause, occurring during the hospitalization in which the operation was performed, even if after 30 days (including patients transferred to other acute care facilities); and (2) all deaths, regardless of cause, occurring after discharge from the hospital, but before the end of the 30 postoperative day. The STS CHSD Mortality Risk Model has good model fit and discrimination with an overall C statistics of 0.875 and 0.858 in the development sample and the validation sample, respectively. These C statistics are the highest C statistics ever seen in a pediatric cardiac surgical risk model. Therefore, the STS CHSD Mortality Risk Model provides excellent adjustment for case mix and should mitigate against risk aversive behavior. The STS CHSD Mortality Risk Model is the best available model to date for measuring outcomes after pediatric cardiac surgery. As of March 2016, 60% of participants in STS CHSD have agreed to publicly report their outcomes through the STS Public Reporting Online website (http://www.sts.org/quality-research-patient-safety/sts-public-reporting-online). Although several opportunities exist to improve our risk models, the current STS CHSD public reporting initiative provides the tools to report publicly, and with meaning and accuracy, the outcomes of congenital and pediatric cardiac surgery.

摘要

胸外科医师协会(STS)先天性心脏病手术数据库(CHSD)公开报告计划基于三项基本原则:(1)先天性和小儿心脏手术结果存在差异。(2)患者及其家属有权了解他们即将接受的治疗结果。(3)我们有专业责任以他们能够理解的形式与他们分享这些信息。STS CHSD公开报告计划利用STS CHSD死亡率风险模型,促进先天性和小儿心脏手术结果的自愿透明公开报告。STS CHSD死亡率风险模型用于计算风险调整后的手术死亡率,并针对以下变量进行调整:年龄、主要手术、体重(新生儿和婴儿)、既往心胸手术、非心脏先天性解剖异常、染色体异常或综合征、早产(新生儿和婴儿)以及术前因素(包括术前/术前机械循环支持[主动脉内球囊泵、心室辅助装置、体外膜肺氧合或心肺支持]、休克[手术时持续存在]、用于治疗心肺衰竭的机械通气、需要透析和/或肾功能不全的肾衰竭、术前神经功能缺损以及其他术前因素)。在所有STS数据库中,手术死亡率定义为:(1)在进行手术的住院期间发生的所有死亡,无论原因如何,即使在30天后(包括转至其他急性护理机构的患者);(2)出院后但在术后30天结束前发生的所有死亡,无论原因如何。STS CHSD死亡率风险模型具有良好的模型拟合度和区分度,在开发样本和验证样本中的总体C统计量分别为0.875和0.858。这些C统计量是小儿心脏手术风险模型中见过的最高C统计量。因此,STS CHSD死亡率风险模型对病例组合提供了出色的调整,应能减轻规避风险行为。STS CHSD死亡率风险模型是迄今为止用于衡量小儿心脏手术后结果的最佳可用模型。截至2016年3月,STS CHSD中60%的参与者已同意通过STS公开报告在线网站(http://www.sts.org/quality-research-patient-safety/sts-public-reporting-online)公开报告他们的结果。尽管有几个机会可以改进我们的风险模型,但当前的STS CHSD公开报告计划提供了公开报告先天性和小儿心脏手术结果的工具,且报告具有意义和准确性。

相似文献

1
The Society of Thoracic Surgeons Congenital Heart Surgery Database Public Reporting Initiative.胸外科医师协会先天性心脏病手术数据库公开报告倡议
Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2017 Jan;20:43-48. doi: 10.1053/j.pcsu.2016.09.008.
2
The science of assessing the outcomes and improving the quality of the congenital and paediatric cardiac care.评估先天性和儿科心脏护理结果并提高其质量的科学。
Curr Opin Cardiol. 2015 Jan;30(1):100-11. doi: 10.1097/HCO.0000000000000133.
3
Mortality Trends in Pediatric and Congenital Heart Surgery: An Analysis of The Society of Thoracic Surgeons Congenital Heart Surgery Database.小儿及先天性心脏病手术的死亡率趋势:胸外科医师协会先天性心脏病手术数据库分析
Ann Thorac Surg. 2016 Oct;102(4):1345-52. doi: 10.1016/j.athoracsur.2016.01.071. Epub 2016 Aug 31.
4
The importance of patient-specific preoperative factors: an analysis of the society of thoracic surgeons congenital heart surgery database.患者特异性术前因素的重要性:对胸外科医师协会先天性心脏病手术数据库的分析
Ann Thorac Surg. 2014 Nov;98(5):1653-8; discussion 1658-9. doi: 10.1016/j.athoracsur.2014.07.029. Epub 2014 Sep 26.
5
The Society of Thoracic Surgeons Congenital Heart Surgery Database Mortality Risk Model: Part 2-Clinical Application.胸外科医师协会先天性心脏病手术数据库死亡风险模型:第2部分 - 临床应用
Ann Thorac Surg. 2015 Sep;100(3):1063-8; discussion 1068-70. doi: 10.1016/j.athoracsur.2015.07.011. Epub 2015 Aug 3.
6
The Society of Thoracic Surgeons Congenital Heart Surgery Database: 2016 Update on Research.胸外科医师协会先天性心脏病手术数据库:2016年研究更新
Ann Thorac Surg. 2016 Sep;102(3):688-695. doi: 10.1016/j.athoracsur.2016.07.015. Epub 2016 Aug 1.
7
Transparency and Public Reporting of Pediatric and Congenital Heart Surgery Outcomes in North America.北美小儿及先天性心脏病手术结果的透明度与公开报告
World J Pediatr Congenit Heart Surg. 2016 Jan;7(1):49-53. doi: 10.1177/2150135115619161.
8
The Society of Thoracic Surgeons Congenital Heart Surgery Database: 2023 Update on Outcomes and Research.美国胸外科协会先天性心脏病外科学会数据库:2023 年关于结果和研究的更新。
Ann Thorac Surg. 2024 May;117(5):904-914. doi: 10.1016/j.athoracsur.2024.03.018. Epub 2024 Mar 24.
9
The Society of Thoracic Surgeons Congenital Heart Surgery Database: 2017 Update on Research.胸外科医师协会先天性心脏病手术数据库:2017年研究更新
Ann Thorac Surg. 2017 Sep;104(3):731-741. doi: 10.1016/j.athoracsur.2017.07.001. Epub 2017 Jul 29.
10
Refining The Society of Thoracic Surgeons Congenital Heart Surgery Database Mortality Risk Model With Enhanced Risk Adjustment for Chromosomal Abnormalities, Syndromes, and Noncardiac Congenital Anatomic Abnormalities.完善胸外科协会先天性心脏病手术数据库死亡率风险模型,增强对染色体异常、综合征和非心脏先天性解剖异常的风险调整。
Ann Thorac Surg. 2019 Aug;108(2):558-566. doi: 10.1016/j.athoracsur.2019.01.069. Epub 2019 Mar 7.

引用本文的文献

1
Longitudinal assessment of health-related quality of life in patients with adult congenital heart disease undergoing cardiac surgery.接受心脏手术的成人先天性心脏病患者健康相关生活质量的纵向评估。
JTCVS Open. 2024 Sep 20;22:407-426. doi: 10.1016/j.xjon.2024.09.011. eCollection 2024 Dec.
2
South-to-south collaboration to strengthen the health workforce: the case of paediatric cardiac surgery in Rwanda.南南合作加强卫生人力:以卢旺达儿科心脏外科学为例。
BMJ Glob Health. 2024 Oct 23;9(10):e015649. doi: 10.1136/bmjgh-2024-015649.
3
Risk of Cardiac Reoperation: An Analysis of The Society of Thoracic Surgeons Congenital Heart Surgery Database.
心脏再次手术风险:胸外科医师学会先天性心脏病数据库分析。
Ann Thorac Surg. 2024 Nov;118(5):1098-1106. doi: 10.1016/j.athoracsur.2024.06.013. Epub 2024 Jun 25.
4
Predictors of major adverse events and complications after ventricular septal defects surgical closure in children less than 10 kg.10 公斤以下儿童室间隔缺损修补术后主要不良事件和并发症的预测因素。
J Cardiothorac Surg. 2022 Sep 7;17(1):232. doi: 10.1186/s13019-022-01985-6.
5
Characterization of "ICU-30": A Binary Composite Outcome for Neonates With Critical Congenital Heart Disease.“ICU-30”的特征:危重新生儿先天性心脏病的二元复合结局。
J Am Heart Assoc. 2022 Jun 21;11(12):e025494. doi: 10.1161/JAHA.122.025494. Epub 2022 Jun 14.
6
Syndromic and Non-Syndromic Patients with Repaired Tetralogy of Fallot: Does It Affect the Long-Term Outcome?法洛四联症修复术后的综合征型与非综合征型患者:这会影响长期预后吗?
J Clin Med. 2022 Feb 6;11(3):850. doi: 10.3390/jcm11030850.
7
Health Care Policy and Congenital Heart Disease: 2020 Focus on Our 2030 Future.医疗保健政策与先天性心脏病:2020 聚焦我们的 2030 未来。
J Am Heart Assoc. 2021 Oct 19;10(20):e020605. doi: 10.1161/JAHA.120.020605. Epub 2021 Oct 8.
8
Prognostic Model to Predict Postoperative Adverse Events in Pediatric Patients With Aortic Coarctation.预测小儿主动脉缩窄患者术后不良事件的预后模型
Front Cardiovasc Med. 2021 May 21;8:672627. doi: 10.3389/fcvm.2021.672627. eCollection 2021.
9
Effect of Trisomy 21 on Postoperative Length of Stay and Non-cardiac Surgery After Complete Repair of Tetralogy of Fallot.21三体综合征对法洛四联症完全修复术后住院时间及非心脏手术的影响。
Pediatr Cardiol. 2019 Dec;40(8):1627-1632. doi: 10.1007/s00246-019-02196-y. Epub 2019 Sep 7.